Literature DB >> 23646886

Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.

Shyam Ramachandran1, Philip H Karp, Samantha R Osterhaus, Peng Jiang, Christine Wohlford-Lenane, Kim A Lennox, Ashley M Jacobi, Kal Praekh, Scott D Rose, Mark A Behlke, Yi Xing, Michael J Welsh, Paul B McCray.   

Abstract

MicroRNAs (miRNAs) are increasingly recognized as important posttranscriptional regulators of gene expression, and changes in their actions can contribute to disease states. Little is understood regarding miRNA functions in the airway epithelium under normal or diseased conditions. We profiled miRNA expression in well-differentiated primary cultures of human cystic fibrosis (CF) and non-CF airway epithelia, and discovered that miR-509-3p and miR-494 concentrations were increased in CF epithelia. Human non-CF airway epithelia, transfected with the mimics of miR-509-3p or miR-494, showed decreased cystic fibrosis transmembrane conductance regulator (CFTR) expression, whereas their respective anti-miRs exerted the opposite effect. Interestingly, the two miRNAs acted cooperatively in regulating CFTR expression. Upon infecting non-CF airway epithelial cells with Staphylococcus aureus, or upon stimulating them with the proinflammatory cytokines TNF-α or IL-1β, we observed an increased expression of both miRNAs and a concurrent decrease in CFTR expression and function, suggesting that inflammatory mediators may regulate these miRNAs. Transfecting epithelia with anti-miRs for miR-509-3p and miR-494, or inhibiting NF-κB signaling before stimulating cells with TNFα or IL-1β, suppressed these responses, suggesting that the expression of both miRNAs was responsive to NF-κB signaling. Thus, miR-509-3p and miR-494 are dynamic regulators of CFTR abundance and function in normal, non-CF airway epithelia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23646886      PMCID: PMC3824042          DOI: 10.1165/rcmb.2012-0430OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  54 in total

1.  Interleukin-1beta regulates CFTR expression in human intestinal T84 cells.

Authors:  E G Cafferata; A M González-Guerrico; L Giordano; O H Pivetta; T A Santa-Coloma
Journal:  Biochim Biophys Acta       Date:  2000-02-21

2.  Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway.

Authors:  Brice Marcet; Benoît Chevalier; Guillaume Luxardi; Christelle Coraux; Laure-Emmanuelle Zaragosi; Marie Cibois; Karine Robbe-Sermesant; Thomas Jolly; Bruno Cardinaud; Chimène Moreilhon; Lisa Giovannini-Chami; Béatrice Nawrocki-Raby; Philippe Birembaut; Rainer Waldmann; Laurent Kodjabachian; Pascal Barbry
Journal:  Nat Cell Biol       Date:  2011-05-22       Impact factor: 28.824

3.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator.

Authors:  Shyam Ramachandran; Philip H Karp; Peng Jiang; Lynda S Ostedgaard; Amy E Walz; John T Fisher; Shaf Keshavjee; Kim A Lennox; Ashley M Jacobi; Scott D Rose; Mark A Behlke; Michael J Welsh; Yi Xing; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

5.  Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma.

Authors:  L J Galietta; C Folli; C Marchetti; L Romano; D Carpani; M Conese; O Zegarra-Moran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-06       Impact factor: 5.464

6.  MicroRNAs can generate thresholds in target gene expression.

Authors:  Shankar Mukherji; Margaret S Ebert; Grace X Y Zheng; John S Tsang; Phillip A Sharp; Alexander van Oudenaarden
Journal:  Nat Genet       Date:  2011-08-21       Impact factor: 38.330

7.  Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 specific binding.

Authors:  Francesca Megiorni; Samantha Cialfi; Carlo Dominici; Serena Quattrucci; Antonio Pizzuti
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

8.  Molecular mechanisms controlling CFTR gene expression in the airway.

Authors:  Zhaolin Zhang; Christopher J Ott; Marzena A Lewandowska; Shih-Hsing Leir; Ann Harris
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

9.  Nucleosome occupancy reveals regulatory elements of the CFTR promoter.

Authors:  Christopher J Ott; Jared M Bischof; Kristen M Unti; Austin E Gillen; Shih-Hsing Leir; Ann Harris
Journal:  Nucleic Acids Res       Date:  2011-09-24       Impact factor: 16.971

10.  Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.

Authors:  Alejandro A Pezzulo; Xiao Xiao Tang; Mark J Hoegger; Mahmoud H Abou Alaiwa; Shyam Ramachandran; Thomas O Moninger; Phillip H Karp; Christine L Wohlford-Lenane; Henk P Haagsman; Martin van Eijk; Botond Bánfi; Alexander R Horswill; David A Stoltz; Paul B McCray; Michael J Welsh; Joseph Zabner
Journal:  Nature       Date:  2012-07-04       Impact factor: 49.962

View more
  41 in total

1.  Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.

Authors:  Shyam Ramachandran; Sateesh Krishnamurthy; Ashley M Jacobi; Christine Wohlford-Lenane; Mark A Behlke; Beverly L Davidson; Paul B McCray
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

Review 2.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

Review 3.  The role of microRNAs in chronic respiratory disease: recent insights.

Authors:  Lindsay R Stolzenburg; Ann Harris
Journal:  Biol Chem       Date:  2018-02-23       Impact factor: 3.915

4.  Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells.

Authors:  Chiara De Santi; Elena Fernández Fernández; Rachel Gaul; Sebastian Vencken; Arlene Glasgow; Irene K Oglesby; Killian Hurley; Finn Hawkins; Nilay Mitash; Fangping Mu; Rana Raoof; David C Henshall; Meritxell B Cutrona; Jeremy C Simpson; Brian J Harvey; Barry Linnane; Paul McNally; Sally Ann Cryan; Ronan MacLoughlin; Agnieszka Swiatecka-Urban; Catherine M Greene
Journal:  Mol Ther       Date:  2020-02-06       Impact factor: 11.454

Review 5.  The innate immune function of airway epithelial cells in inflammatory lung disease.

Authors:  Pieter S Hiemstra; Paul B McCray; Robert Bals
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

6.  Gene-specific MicroRNA antagonism protects against HIV Tat and TGF-β-mediated suppression of CFTR mRNA and function.

Authors:  R K Dutta; S Chinnapaiyan; M J Santiago; I Rahman; H J Unwalla
Journal:  Biomed Pharmacother       Date:  2021-08-27       Impact factor: 7.419

Review 7.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

8.  miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.

Authors:  Sinéad Weldon; Paul McNally; Danny F McAuley; Irene K Oglesby; Christine L Wohlford-Lenane; Jennifer A Bartlett; Christopher J Scott; Noel G McElvaney; Catherine M Greene; Paul B McCray; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

9.  RPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF.

Authors:  Motohiro Tsuchiya; Swathi Kalurupalle; Parameet Kumar; Sarani Ghoshal; Yongqing Zhang; Elin Lehrmann; Kevin G Becker; Myriam Gorospe; Roopa Biswas
Journal:  RNA Biol       Date:  2016-06-10       Impact factor: 4.652

10.  Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation.

Authors:  Ping-Xia Zhang; Jijun Cheng; Siying Zou; Anthony D D'Souza; Jonathan L Koff; Jun Lu; Patty J Lee; Diane S Krause; Marie E Egan; Emanuela M Bruscia
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.